Vasopressin / Desmopressin

Endocrine / Fluid balance

Antidiuretic effect

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: V2 receptor agonism
Primary market use: Diabetes insipidus/nocturia

Pharmacology

Molecular weight (Da): 1084 / 1069
Oral bioavailability: DDAVP oral ~0.1-0.2%
Half-life: VP 10-20 min; DDAVP 2-3 h
Route tags: Route-dependent / verify
Evidence level: Approved
Clinical status: Approved
Value-for-money score: 6 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Transient hormonal effect

Sources

https://www.fda.gov/drugs